These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2831595)

  • 21. A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients.
    Neidhart PP; Champion P; Vogel J; Zsigmond EK; Tassonyi E
    Can J Anaesth; 1994 Jun; 41(6):469-74. PubMed ID: 8069985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromuscular blockade and lung function during resuscitation of infants with congenital diaphragmatic hernia.
    Murthy V; D'Costa W; Nicolaides K; Davenport M; Fox G; Milner AD; Campbell M; Greenough A
    Neonatology; 2013; 103(2):112-7. PubMed ID: 23182955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchospasm in an asthmatic patient following pancuronium.
    Heath ML
    Anaesthesia; 1973 Jul; 28(4):437-40. PubMed ID: 4268667
    [No Abstract]   [Full Text] [Related]  

  • 24. Pancuronium bromide and tachyarrhythmias.
    Anderson EF; Rosenthal MH
    Crit Care Med; 1975; 3(1):13-5. PubMed ID: 1126174
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of resistance to pancuronium in adult respiratory distress syndrome.
    Callanan DL
    Anesth Analg; 1985 Nov; 64(11):1126-8. PubMed ID: 4051209
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe hypertension assoiated with pancuronium bromide.
    Fraley DS; Lemoncelli GL; Coleman A
    Anesth Analg; 1978; 57(2):265-7. PubMed ID: 565166
    [No Abstract]   [Full Text] [Related]  

  • 27. Pancuronium-induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine.
    Miller RD; Eger EI; Stevens WC; Gibbons R
    Anesthesiology; 1975 Mar; 42(3):352-5. PubMed ID: 1115388
    [No Abstract]   [Full Text] [Related]  

  • 28. Tricyclic antidepressants and cardiac arrhythmias during halothane-pancuronium anesthesia.
    Tung A; Chang JL; Garvey E; Bleyaert A
    Anesth Prog; 1981; 28(2):44, 48-9. PubMed ID: 6943946
    [No Abstract]   [Full Text] [Related]  

  • 29. Bradycardia associated with the use of vecuronium. A comparative study with pancuronium with and without glycopyrronium.
    Cozanitis DA; Pouttu J; Rosenberg PH
    Anaesthesia; 1987 Feb; 42(2):192-4. PubMed ID: 2881499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Pancuronium tachycardia.
    JAMA; 1973 Oct; 226(5):568-9. PubMed ID: 4800317
    [No Abstract]   [Full Text] [Related]  

  • 31. Anaphylactoid reaction induced by pancuronium during general anaesthesia.
    Sánchez-Guerrero IM; Tortosa JA; Hernández-Palazón J; Escudero AI
    Eur J Anaesthesiol; 1998 Sep; 15(5):613-4. PubMed ID: 9785081
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination.
    Giostra E; Magistris MR; Pizzolato G; Cox J; Chevrolet JC
    Chest; 1994 Jul; 106(1):210-20. PubMed ID: 8020274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pipecuronium and pancuronium on cerebrospinal fluid pressure in neurosurgical patients.
    Thiel A; Wyderka T; Wagner RM; Ebel H; Hempelmann G
    Acta Anaesthesiol Belg; 1996; 47(2):59-65. PubMed ID: 8869672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular regional wall motion and haemodynamic changes following bolus administration of pipecuronium or pancuronium to adult patients undergoing coronary artery bypass grafting.
    Shorten GD; Sieber T; Maslow AD; Haering JM; Robertson LK; Comunale ME
    Can J Anaesth; 1995 Aug; 42(8):695-700. PubMed ID: 7586108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular blockade for critical patients in the emergency department.
    Roberts DJ; Clinton JE; Ruiz E
    Ann Emerg Med; 1986 Feb; 15(2):152-6. PubMed ID: 3946857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease.
    Sethna DH; Starr NJ; Estafanous FG
    Can J Anaesth; 1987 Nov; 34(6):582-8. PubMed ID: 2890442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient.
    Murphy GS; Szokol JW; Marymont JH; Avram MJ; Vender JS; Rosengart TK
    Anesthesiology; 2002 Mar; 96(3):600-6. PubMed ID: 11873034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isorhythmic atrioventricular dissociation following pancuronium.
    Fonsmark L; Wolff J
    Acta Anaesthesiol Scand; 1991 Oct; 35(7):680-1. PubMed ID: 1785252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report.
    Geha DG; Blitt CD; Moon BJ
    Anesth Analg; 1976; 55(3):343-5. PubMed ID: 945014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histamine plasma concentration and cardiovascular effects of non-depolarizing muscle relaxants: comparison of atracurium, vecuronium, pancuronium and pipecuronium in coronary surgical patients at risk].
    Brinkmann M; Günnicker M; Freund U; Schieffer M; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):362-6. PubMed ID: 9689393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.